Verastem Inc

Verastem Inc is an American biopharmaceutical company focused on developing and commercialising innovative oncology treatments. Its primary aim is to improve the lives of cancer patients through targeted therapies that address underlying disease mechanisms. Operating within the biotechnology sector, Verastem Inc specialises in advancing small molecule drugs. The company's specific approach involves targeting critical signalling pathways to develop therapies aimed at difficult-to-treat solid tumours. Keep up to date on the latest share price changes by adding VSTM stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.